Page not found
HOME / Page not found

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (522)

Friday, 03 November 2023 16:07

Stefania Crucitta

Written by
Friday, 03 November 2023 16:07

Simonetta Buglioni

Written by
Friday, 03 November 2023 16:07

Helena Bote De Cabo

Written by
Friday, 03 November 2023 16:07

Isabel Barragan

Written by
Friday, 03 November 2023 16:06

Ian Silverman

Written by
Thursday, 12 October 2023 12:54

Maria Arcila

Written by
Thursday, 12 October 2023 12:53

Nicola Fusco

Written by
Prof. Nicola Fusco is Director of the Division of Pathology at IEO European Institute of Oncology IRCCS, Milan, Italy and is an Associate Professor at the Department of Oncology and Hemato-Oncology, University of Milan. He also leads our IEO Biobank for Translational and Digital Medicine Unit. Prof. Fusco is a member of a global network of experts in predictive oncologic pathology, specializing in tissue and liquid biopsy. He is recognized as an expert in digital pathology and applications of artificial intelligence in diagnostic pathology.
Thursday, 12 October 2023 12:53

Simon Patton

Written by
Thursday, 12 October 2023 12:52

Atocha Romero

Written by
Atocha Romero is a Laboratory Medicine specialist who holds a Ph.D. in Molecular Biology from Universidad Complutense de Madrid. Presently, Dr. Romero serves as the director of the Liquid Biopsy Laboratory (LBL), from the medical Oncology Department, at Puerta de Hierro Hospital, in Madrid. The LBL provides diagnostic services and undertakes research in the field of cancer biomarkers. Her research predominantly focuses on the applicability of liquid biopsies in lung cancer patients. Her research has consistently secured funding through competitive public grant calls. With over 90 publications in international journals to her name, she has also overseen multiple theses.
Thursday, 12 October 2023 12:51

Andrea D'Ambrogio

Written by
Andrea earned his MSc in Biotechnology and PhD form the University of Trieste in Italy. During his postdocs at University of Massachussetts in the US and Laboratory of Molecular Biology in Cambridge UK he developed NGS library prep methods to clone small RNAs and RNAs attached to RNA binding proteins uncovering aberrant gene regulation of genes such as p53. He then moved to industry to Horizon Discovery in Cambridge UK to develop and launch several reference standards (including liquid biopsy!) widely used by molecular diagnostics technology developers such as Thermo, Illumina and Archer to set-up their assays, and now used in external quality assessment schemes to test labs ability to call the right alterations in cancer patient samples. After working on exosomes for a small Italian startup then acquired by Lonza he now works in Precision Oncology at Roche/Foundation Medicine where he tries every day to ‘do now what patients need next’.
Page 23 of 38